Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Epigenetic mechanisms and therapeutic advances in breast cancer: From molecular insights to clinical applications

Advances in cancer research(2025)10.1016/bs.acr.2025.08.002Source: DataRank Database

Epigenetic mechanisms and therapeutic advances in breast cancer: From molecular insights to clinical applications is a research paper published in Advances in cancer research (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

2 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 7.25)OA: closedTopics (32)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Joseph W. Landry ORCID,Swadesh K. Das ORCID,Paul B. Fisher ORCID,Shahid Maqbool Mir

Live enrichment

PubMed:41242857 OpenAlex:https://openalex.org/W4414574858

National Cancer Institute

Grant: R01 CA280194

National Cancer Institute

Grant: R01 CA244993

National Cancer Institute

Grant: R01 CA259599

National Cancer Institute

Grant: P01 CA275740

FWCI

7.25

Citation Percentile

1.0%

Citation Trend

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S0065230X25000508?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0065230X25000508?httpAccept=text/plain

book serieshttps://doi.org/10.1016/bs.acr.2025.08.002

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41242857

Fields of Study

Histone Deacetylase Inhibitors ResearchEpigenetics and DNA MethylationProtein Degradation and Inhibitors

MeSH Terms

AnimalsBreast NeoplasmsFemaleHumansBiomarkers, TumorGene Expression Regulation, NeoplasticDNA MethylationEpigenesis, Genetic

Keywords

EpigeneticsHistonemicroRNABreast cancerChromatinDNA methylationChromatin remodelingEpigenesisCancerDrug resistanceGene silencingBiomarkersHistone acetylationmicroRNAsNon-coding RnasLong Non-coding RnasPrecision MedicineLiquid BiopsyEpigenetic DrugsBrca1 And Rassf1aHistone Changes

Epigenetic mechanisms and therapeutic advances in breast cancer: From molecular insights to clinical applications

FAIR Checklist

Authors (4)

Funding (4 grants)

Impact

Open Access

Topics